Richard P. Harbottle

3.4k citations

71 papers · 2.3k indexed · h-index 28

Genetics top 2%
- Virus-based gene therapy research 31
Molecular Biology top 5%
- RNA Interference and Gene Delivery 33
- CRISPR and Genetic Engineering 16
- Advanced biosensing and bioanalysis techniques 10
- Viral Infectious Diseases and Gene Expression in Insects 6
Immunology and Allergy top 10%
Immunology top 10%
- Immunotherapy and Immune Responses 6
Biomaterials top 10%
Oncology
- CAR-T cell therapy research 6
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 4

Co-authors: Charles Coutelle Andrew D. Miller Stephen L. Hart Suet Ping Wong Orestis Argyros Andrew M. Knight RG Cooper Suet‐Ping Wong
Cited by: Genetics Molecular Biology Immunology and Allergy
Journals: Journal of Biological Chemistry (2 papers)Angewandte Chemie International Edition (1 paper)Nature Biotechnology (1 paper)
Partner nations: United Kingdom Germany United States

In The Last Decade

Richard P. Harbottle

66 papers receiving 2.2k citations

Peers

Countries citing papers authored by Richard P. Harbottle

Since Specialization

Citations

This map shows the geographic impact of Richard P. Harbottle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard P. Harbottle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard P. Harbottle more than expected).

Fields of papers citing papers by Richard P. Harbottle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard P. Harbottle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard P. Harbottle. The network helps show where Richard P. Harbottle may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Richard P. Harbottle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Richard P. Harbottle Line = papers co-authored together Richard P. Harbottle links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Erythropoietin delivery through kidney organoids engineered with an episomal DNA vector Stem Cell Research & Therapy ·Zhaoyu Du,Amanda Bas-Cristóbal Menéndez,Matthew W. Urban,Adam Hartley,Danielle Ratsma,Marijke Koedam,Thierry van den Bosch,Marian C. Clahsen‐van Groningen,Joost Gribnau,Jaap Mulder,Marlies E. J. Reinders,Carla C. Baan,Bram C. J. van der Eerden,Richard P. Harbottle,Martin J. Hoogduijn	2025	0
2	Development of an Orthotopic HPV16-Dependent Base of Tongue Tumor Model in MHC-Humanized Mice Pathogens ·Christoph Schifflers,Samantha Zottnick,Jonas D. Förster,Sebastian Kruse,Ruwen Yang,Hendrik Wiethoff,Matthias Bozza,Karin Hoppe‐Seyler,Mathias Heikenwälder,Richard P. Harbottle,Carine Michiels,Angelika B. Riemer	2023	0
3	P06.05.A INTRACEREBROVENTRICULAR TCR-TRANSGENIC T CELL THERAPY TO TREAT GLIOBLASTOMA (INVENT4GB) Neuro-Oncology ·Lukas Bunse,Markus Kratzmann,Yun-Ting Chih,Khwab Sanghvi,Alice De Roia,Richard P. Harbottle,Stefan B. Eichmüller,Axel Benner,E Green,Isabel Poschke,Patrick Schmidt,Joachim P. Steinbach,Peter Vajkoczy,Lars Bullinger,Ghazaleh Tabatabai,Miriam Stenzinger,Halvard Bönig,Wolfgang Wick,Michael Platten	2023	1
4	Successful large gene augmentation of USH2A with non-viral episomal vectors Molecular Therapy ·Maria Toms,Lyes Toualbi,Patrick Almeida,Richard P. Harbottle,Mariya Moosajee	2023	14
5	Gene Augmentation of CHM Using Non-Viral Episomal Vectors in Models of Choroideremia International Journal of Molecular Sciences ·Lyes Toualbi,Maria Toms,Patrick Almeida,Richard P. Harbottle,Mariya Moosajee	2023	3
6	NLGN4X TCR transgenic T cells to treat gliomas Neuro-Oncology ·Christoper Krämer,Michael Kilian,Yu‐Chan Chih,Alexandros Kourtesakis,Dirk C. Hoffmann,Tamara Boschert,P. Koopmann,Khwab Sanghvi,Alice De Roia,Stefanie Jung,Kristine Jähne,Bryan W. Day,Lenny D Shultz,Miriam Ratliff,Richard P. Harbottle,Edward W. Green,Rainer Will,Wolfgang Wick,Michael Platten,Lukas Bunse	2023	9
7	An episomal DNA vector platform for the persistent genetic modification of pluripotent stem cells and their differentiated progeny Stem Cell Reports ·Alicia Roig‐Merino,Manuela Urban,Matthias Bozza,Julia D. Peterson,Louise F. Bullen,Marleen Büchler-Schäff,Sina Stäble,Franciscus van der Hoeven,Karin Müller‐Decker,Tristan R. McKay,Michael D. Milsom,Richard P. Harbottle	2021	19
8	Novel Non-integrating DNA Nano-S/MAR Vectors Restore Gene Function in Isogenic Patient-Derived Pancreatic Tumor Models Molecular Therapy — Methods & Clinical Development ·Matthias Bozza,Edward W. Green,Elisa Espinet,Alice De Roia,Corinna Klein,Vanessa Vogel,Rienk Offringa,James A. Williams,Martin R. Sprick,Richard P. Harbottle	2020	23
9	Beta HPV38 oncoproteins act with a hit-and-run mechanism in ultraviolet radiation-induced skin carcinogenesis in mice PLoS Pathogens ·Daniele Viarisio,Karin Müller‐Decker,Rosita Accardi,Alexis Robitaille,Matthias Dürst,Katrin Beer,Lars Jansen,Christa Flechtenmacher,Matthias Bozza,Richard P. Harbottle,Catherine Voegele,Maude Ardin,Jiří Zavadil,Sandra Caldeira,Lutz Gissmann,Massimo Tommasino	2018	83
10	Safety Profile of Stromal Hydration of Clear Corneal Incisions with Cefuroxime in the Mouse Model Journal of Ocular Pharmacology and Therapeutics ·Mariya Moosajee,Dhani Tracey‐White,Richard P. Harbottle,Veronica Ferguson	2016	0
11	Sustained Expression from DNA Vectors Advances in genetics ·Suet Ping Wong,Orestis Argyros,Richard P. Harbottle	2014	22
12	Genetic modification of dividing cells using episomally maintained S/MAR DNA vectors Molecular Therapy — Nucleic Acids ·Suet‐Ping Wong,Richard P. Harbottle	2013	7
13	Minimal-length Synthetic shRNAs Formulated with Lipid Nanoparticles are Potent Inhibitors of Hepatitis C Virus IRES-linked Gene Expression in Mice Molecular Therapy — Nucleic Acids ·Anne Dallas,Heini Ilves,Joshua Shorenstein,Adam D. Judge,Ryan Spitler,Christopher H. Contag,Suet Ping Wong,Richard P. Harbottle,Ian MacLachlan,Brian H. Johnston	2013	14
14	Persistent Expression of Non-Viral S/MAR Vectors in the RPE for Choroideremia Gene Therapy Investigative Ophthalmology & Visual Science ·Elham Ostad-Saffari,Mariya Moosajee,Suet Ping Wong,Dhani Tracey‐White,Tanya Tolmachova,Richard P. Harbottle,Miguel C. Seabra	2010	2
15	Non-viral S/MAR vectors replicate episomally in vivo when provided with a selective advantage Gene Therapy ·Suet Ping Wong,Orestis Argyros,Charles Coutelle,Richard P. Harbottle	2010	33
16	LDLR-Gene therapy for familial hypercholesterolaemia: problems, progress, and perspectives International Archives of Medicine ·Faisal A. Al-Allaf,Charles Coutelle,Simon N. Waddington,Anna L. David,Richard P. Harbottle,Michael Themis	2010	39
17	Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector Gene Therapy ·Orestis Argyros,Suet Ping Wong,Marcello Niceta,Simon N. Waddington,Steven J. Howe,Charles Coutelle,Andrew D. Miller,Richard P. Harbottle	2008	73
18	Nuclear Localisation Sequence Templated Nonviral Gene Delivery Vectors: Investigation of Intracellular Trafficking Events of LMD and LD Vector Systems ChemBioChem ·Michael Keller,Richard P. Harbottle,Éric Pérouzel,Morvane Colin,Syed Imran Ali Shah,Rahimin Affandi Abdul Rahim,Laurence Vaysse,Anna Bergau,S. Moritz,Christiane Brahimi‐Horn,Charles Coutelle,Andrew D. Miller	2003	59
19	An RGD–Oligolysine Peptide: A Prototype Construct for Integrin-Mediated Gene Delivery Human Gene Therapy ·Richard P. Harbottle,Robert G. Cooper,Stephen L. Hart,Axel Ladhoff,Tristan R. McKay,Andrew M. Knight,Ernst Wagner,Andrew D. Miller,Charles Coutelle	1998	149
20	A novel peptide, PLAEIDGIELTY, for the targeting of α₉β₁‐integrins FEBS Letters ·Holm Schneider,Richard P. Harbottle,Yasuyuki Yokosaki,Jan Kunde,Dean Sheppard,Charles Coutelle	1998	23

About Richard P. Harbottle

Richard P. Harbottle is a scholar working on Genetics, Molecular Biology and Immunology and Allergy, having authored 71 papers that have together received 2.3k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (33 papers), Virus-based gene therapy research (31 papers), CRISPR and Genetic Engineering (16 papers), Advanced biosensing and bioanalysis techniques (10 papers), Immunotherapy and Immune Responses (6 papers), CAR-T cell therapy research (6 papers), Viral Infectious Diseases and Gene Expression in Insects (6 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Genetics (988 citations), Molecular Biology (1.7k citations) and Immunology and Allergy (76 citations). Richard P. Harbottle has collaborated with scholars based in United Kingdom, Germany and United States. Frequent co-authors include Charles Coutelle, Andrew D. Miller, Stephen L. Hart, Suet Ping Wong, Orestis Argyros, Andrew M. Knight, RG Cooper, Suet‐Ping Wong, Simon N. Waddington and Matthias Bozza. Their work appears in journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Biotechnology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact